Gsk (GSK) Current Assets (2009 - 2026)

Gsk (GSK) has 18 years of Current Assets data on file, last reported at $23.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Current Assets changed 0.08% year-over-year to $23.6 billion; the trailing twelve-month figure through Jun 2026 stood at $23.6 billion (changed 0.08% YoY), and the FY2025 full-year result was $23.3 billion, up 7.2% from the prior year.
• Current Assets was $23.6 billion for Q2 2026 at Gsk, down from $23.9 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $68.2 billion in Q2 2022 to a low of $20.5 billion in Q1 2022.
• A 5-year average of $25.8 billion and a median of $23.6 billion in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 177.93% in 2022 and sank 64.52% in 2023, its largest moves.
• Gsk's Current Assets stood at $24.4 billion in 2022, then declined by 5.01% to $23.1 billion in 2023, then dropped by 5.72% to $21.8 billion in 2024, then advanced by 6.76% to $23.3 billion in 2025, then increased by 1.15% to $23.6 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $23.6 billion in Q2 2026, $23.9 billion in Q1 2026, and $23.3 billion in Q4 2025.